Europe Biobanks Drug Discovery and Regenerative Medicine Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

A biobank is a type of biorepository which stores the biological samples, usual humans for research in genetics and microbiology. Biobanking drug discovery & regenerative medicine is used to conduct various analysis, researches and for the storage of the samples. In many types of research, biological samples are used to manufacture regenerative medicine and to study different types of diseases.

Europe Biobank Drug Discovery & Regenerative Medicine Market Segments Size & Growth:

Europe biobank drug discovery & regenerative medicine market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market are increasing demand for precision medicine, research for clinical trials, and advancement in biobanking techniques. However, surveillance issues, storage problem, and the high cost of procedures hinder the growth of the Europe biobank market.

Europe Biobank Drug Discovery & Regenerative Medicine Market Segments Share:

Europe biobank drug discovery & regenerative medicine market is categorised into by type which consists of drug discovery & regenerative medicine such as regenerative medicine, life science research, disease research, and drug discovery. Drug discovery and regenerative medicine have the most significant share as they can produce a precision medicine to cure chronic diseases.

By Geography, Germany is dominating the biobank drug discovery & regenerative medicine market and the growth in Europe are mainly attributed because of the increasing adoption of personalised medicine and research activities. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising ageing population, diseases and investment in R&D research.

Europe Biobank Drug Discovery & Regenerative Medicine Market Segments Trends:

• In January 2017, Tecan has brought a new handling biological fluids arm Air LiHa which helps in collecting complex liquids in biobanks and clinical trials.
• In April 2017, Micronics tubes are used to store gynaecological samples by Clinical Cytology biobank at Sweden Karolinska Institute to provide high integrity storage and traceable device.
• In January 2017, Qiagen bioinformatics has acquired Omic Soft Corporation providing access to the multi-omics database.
• In May 2017, Thermo Fisher Scientific Inc. has been acquired with Patheon a Contract Development and Manufacturing Company

Europe Biobank Drug Discovery & Regenerative Medicine Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Hamilton Company
• Chart Industries, Inc.
• BioCision
• DNA Genotek Inc.
• Taylor-Wharton